Scott Gottlieb, the FDAs former commissioner, said on CNBC that many of the compounds wont deliver the expected benefit. The agencys safety concerns appear to be well founded: between February 2019 and December 2023, the FDA received 352 adverse event reports related to compounded GLP-1 drugs, including five deaths
According to FDA-approved prescribing information, gastrointestinal adverse effects occur commonly with these medications, with nausea reported in 16-44% of patients, vomiting in 6-24%, and abdominal pain or distension in 5-18%, depending on the specific medication and dosage
It is routinely used by people, including: Adults suffering from age-related GH decline Those experiencing fatigue, poor recovery, muscle-wasting or weight gain issues resulting from normal growth hormone decline as we age
Here, we review key developments in type 2 diabetes initiation, progression and remission, focusing mostly on human studies published in the last 5 years
What is the maximum BPC-157 dosage
PMID 25587655